![]() They represent just 3 percent of the population.īut a new monoclonal antibody drug from AstraZeneca called AZD7442 appears to bolster protection significantly. About 40 percent of all breakthrough infections have occurred in the immunocompromised. The retired physician from the Los Angeles area is one of about 200,000 Americans living with chronic lymphocytic leukemia, a type of blood cancer that seriously weakens his ability to make antibodies and fight infections.įor him, even three doses of a vaccine might not be enough. SAN DIEGO (KGTV) - The Food and Drug Administration is reviewing a new antibody drug for COVID-19 that could significantly improve protection for people at the highest risk: those with compromised immune systems.ĭr.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |